Your browser doesn't support javascript.
loading
Fecal Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-Cov-2) RNA Is Associated With Decreased Coronavirus Disease 2019 (COVID-19) Survival.
Das Adhikari, Upasana; Eng, George; Farcasanu, Mara; Avena, Laura E; Choudhary, Manish C; Triant, Virginia A; Flagg, Meaghan; Schiff, Abigail E; Gomez, Isabella; Froehle, Leah M; Diefenbach, Thomas J; Ronsard, Larance; Lingwood, Daniel; Lee, Grace C; Rabi, Seyed Alireza; Erstad, Derek; Velmahos, George; Li, Jonathan Z; Hodin, Richard; Stone, James R; Honko, Anna N; Griffiths, Anthony; Yilmaz, Ömer H; Kwon, Douglas S.
Affiliation
  • Das Adhikari U; Ragon Institute of Massachusetts General Hospital, Massachusetts Institute of Technology, and Harvard, Cambridge, Massachusetts, USA.
  • Eng G; Harvard Medical School, Boston, Massachusetts, USA.
  • Farcasanu M; Harvard Medical School, Boston, Massachusetts, USA.
  • Avena LE; Department of Pathology, Massachusetts General Hospital, Boston, Massachusetts, USA.
  • Choudhary MC; Koch Institute, Massachusetts Institute of Technology, Cambridge, Massachusetts, USA.
  • Triant VA; Ragon Institute of Massachusetts General Hospital, Massachusetts Institute of Technology, and Harvard, Cambridge, Massachusetts, USA.
  • Flagg M; Harvard Medical School, Boston, Massachusetts, USA.
  • Schiff AE; Department of Microbiology and National Emerging Infectious Diseases Laboratories, Boston University School of Medicine, Boston, Massachusetts, USA.
  • Gomez I; Division of Infectious Diseases, Brigham and Women's Hospital, Boston, Massachusetts, USA.
  • Froehle LM; Division of Infectious Diseases, Massachusetts General Hospital, Boston, Massachusetts, USA.
  • Diefenbach TJ; Ragon Institute of Massachusetts General Hospital, Massachusetts Institute of Technology, and Harvard, Cambridge, Massachusetts, USA.
  • Ronsard L; Ragon Institute of Massachusetts General Hospital, Massachusetts Institute of Technology, and Harvard, Cambridge, Massachusetts, USA.
  • Lingwood D; Harvard Medical School, Boston, Massachusetts, USA.
  • Lee GC; Ragon Institute of Massachusetts General Hospital, Massachusetts Institute of Technology, and Harvard, Cambridge, Massachusetts, USA.
  • Rabi SA; Ragon Institute of Massachusetts General Hospital, Massachusetts Institute of Technology, and Harvard, Cambridge, Massachusetts, USA.
  • Erstad D; Ragon Institute of Massachusetts General Hospital, Massachusetts Institute of Technology, and Harvard, Cambridge, Massachusetts, USA.
  • Velmahos G; Ragon Institute of Massachusetts General Hospital, Massachusetts Institute of Technology, and Harvard, Cambridge, Massachusetts, USA.
  • Li JZ; Ragon Institute of Massachusetts General Hospital, Massachusetts Institute of Technology, and Harvard, Cambridge, Massachusetts, USA.
  • Hodin R; Division of Surgery, Massachusetts General Hospital, Boston, Massachusetts, USA.
  • Stone JR; Division of Surgery, Massachusetts General Hospital, Boston, Massachusetts, USA.
  • Honko AN; Division of Surgery, Massachusetts General Hospital, Boston, Massachusetts, USA.
  • Griffiths A; Division of Surgery, Massachusetts General Hospital, Boston, Massachusetts, USA.
  • Yilmaz ÖH; Harvard Medical School, Boston, Massachusetts, USA.
  • Kwon DS; Division of Infectious Diseases, Brigham and Women's Hospital, Boston, Massachusetts, USA.
Clin Infect Dis ; 74(6): 1081-1084, 2022 03 23.
Article in En | MEDLINE | ID: mdl-34245255
Subject(s)
Key words
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: SARS-CoV-2 / COVID-19 Type of study: Risk_factors_studies Limits: Humans Language: En Journal: Clin Infect Dis Year: 2022 Document type: Article
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: SARS-CoV-2 / COVID-19 Type of study: Risk_factors_studies Limits: Humans Language: En Journal: Clin Infect Dis Year: 2022 Document type: Article